Home/Filings/4/0001140361-07-024881
4//SEC Filing

LYONDELL CHEMICAL CO 4

Accession 0001140361-07-024881

CIK 0000842635operating

Filed

Dec 19, 7:00 PM ET

Accepted

Dec 20, 2:05 PM ET

Size

30.8 KB

Accession

0001140361-07-024881

Insider Transaction Report

Form 4
Period: 2007-12-20
HALL CHARLES L
Vice President and Controller
Transactions
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2007-12-20$35.13/sh30,689$1,078,1050 total
    Exercise: $12.87Exp: 2013-02-07Common Stock (30,689 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2007-12-20$30.45/sh11,295$343,9330 total
    Exercise: $17.55Exp: 2014-02-05Common Stock (11,295 underlying)
  • Disposition to Issuer

    Common Stock

    2007-12-2027,8280 total
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2007-12-20$19.44/sh9,609$186,7990 total
    Exercise: $28.56Exp: 2015-01-20Common Stock (9,609 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2007-12-20$34.20/sh41,701$1,426,1740 total
    Exercise: $13.80Exp: 2012-02-08Common Stock (41,701 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2007-12-20$23.48/sh14,321$336,2570 total
    Exercise: $24.52Exp: 2016-02-23Common Stock (14,321 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2007-12-20$16.03/sh15,522$248,8180 total
    Exercise: $31.97Exp: 2017-02-22Common Stock (15,522 underlying)
  • Award

    Common Stock

    2007-12-20+16,19344,021 total
  • Disposition to Issuer

    Common Stock

    2007-12-20$48.00/sh16,193$777,26427,828 total
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2007-12-20$35.21/sh5,000$176,0500 total
    Exercise: $12.79Exp: 2011-09-10Common Stock (5,000 underlying)
  • Disposition to Issuer

    Phantom Stock

    2007-12-20$48.00/sh3,373$161,9040 total
    Common Stock (3,373 underlying)
Footnotes (10)
  • [F1]This reports the payout of performance awards denominated in shares of Lyondell?s common stock, on the effective date of the merger pursuant to the Merger Agreement between Lyondell and Basell and BIL Acquisition Holdings Limited (?Merger Agreement?) for the merger consideration of $48 per share.
  • [F10]Phantom Stock which convert on a 1 for 1 basis and provided for vesting in 3 equal annual installments beginning one year from the date of grant, was disposed of on the effective date of the merger pursuant to the Merger Agreement for the merger consideration of $48 per share.
  • [F2]Shares of common stock disposed of on the effective date of the merger pursuant to the Merger Agreement for the merger consideration of $48 per share.
  • [F3]The options, which vested on August 21, 2002 in connection with Lyondell's purchase of Occidental Petroleum Corporation's interest in Equistar Chemicals, LP, were canceled pursuant to the Merger Agreement in exchange for a cash payment of $176,050.00 representing the difference between the exercise price of the option and the $48 per share merger consideration.
  • [F4]The options, 2/3 which vested ratably on February 8, 2003 and February 8, 2004 and 1/3 vested on December 1, 2004 in connection with the acquisition of Millennium Chemicals Inc., were canceled pursuant to the Merger Agreement in exchange for a cash payment of $1,426,174.20 representing the difference between the exercise price of the option and the $48 per share merger consideration.
  • [F5]The options, 1/3 which vested on February 7, 2007 and 2/3 on November 23, 2004 because the Lyondell common stock price became two times the exercise price of the stock option, were canceled pursuant to the Merger Agreement in exchange for a cash payment of $1,078,104.57 representing the difference between the exercise price of the option and the $48 per share merger consideration.
  • [F6]The options, which vested on December 1, 2004 in connection with the acquisition of Millennium Chemicals Inc., were canceled pursuant to the Merger Agreement in exchange for a cash payment of $343,932.75 representing the difference between the exercise price of the option and the $48 per share merger consideration.
  • [F7]The options, which 2/3 vested ratably on January 20, 2006 and January 20, 2007 and 1/3 vested on November 20, 2007 in connection with shareholder approval of the merger, were canceled pursuant to the Merger Agreement in exchange for a cash payment of $186,798.96 representing the difference between the exercise price of the option and the $48 per share merger consideration.
  • [F8]The options, which 2/3 vested ratably on January 20, 2006 and January 20, 2007 and 1/3 vested on November 20, 2007 in connection with shareholder approval of the merger, were canceled pursuant to the Merger Agreement in exchange for a cash payment of $336,257.08 representing the difference between the exercise price of the option and the $48 per share merger consideration.
  • [F9]The options, which vested on the effective date of the merger, were canceled pursuant to the Merger Agreement in exchange for a cash payment of $248,817.66 representing the difference between the exercise price of the option and the $48 per share merger consideration.

Documents

1 file

Issuer

LYONDELL CHEMICAL CO

CIK 0000842635

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000842635

Filing Metadata

Form type
4
Filed
Dec 19, 7:00 PM ET
Accepted
Dec 20, 2:05 PM ET
Size
30.8 KB